ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2022 - Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

Date2022-03-31 - 2022-04-01

Deadline2022-03-21

VenueVirtual Seminar, USA - United States USA - United States

Keywords

Websitehttps://www.complianceonline.com/fda-eu-...

Topics/Call fo Papers

What FDA segments are included and excluded within the "NEW" Process Validation.
Where does the Process Validation commence.
What are the Three Stages and Where They Apply within the NEW Process Validation.
How Stage 1 integrates with Phase 1.
The Validation approaches that are included within this Guidance document.
The Statutory and Regulatory Requirements for Process Validation.
An Introduction to Phase 1 Guidance for Industry and Its Application within the "NEW" Process Validation.
The Phase 1 Investigational Drug Requirements -- What is and What is NOT Required.
General Considerations for Process Validation - Stage 2 Process Qualification.
Regulatory Strategies for Phase 2 and 3 and their Incorporation within Stages 1 and 2.
General Considerations for Process Validation - Stage 3 Continued Process Verification.
A Review of EU Annex 15 and its Comparison to FDA’s Process Validation Guidance.

Last modified: 2022-03-20 03:02:50